High-intensity Raf signal causes cell cycle arrest mediated by p21(Cip1)

Molecular and Cellular Biology

Volumn 17, Issue 9, 1997, Pages 5588-5597

  Sewing, Andreas ^a   Wiseman, Bryony ^a   Lloyd, Alison C ^a   Land, Hartmut ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; EMBRYO; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALIA; MURINAE;

EID: 0030871667     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.9.5588     Document Type: Article

References (97)

1. Ahn, N. G., R. Seger, R. L. Bratlien, C. D. Diltz, N. K. Tonks, and E. G. Krebs. 1991. Multiple components in an epidermal growth factor-stimulated protein kinase cascade. In vitro activation of a myelin basic protein/microtubule associated protein 2 kinase. J. Biol. Chem. 266:4220-4227.
2. Beck, T. W., M. Huleihel, M. A. Gunnell, T. I. Bonner, and U. R. Rapp. 1987. The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus. Nucleic Acids Res. 15:595-609.
3. Blasi, E., B. J. Mathieson, L. Varesio, J. L. Cleveland, P. A. Borchert, and U. R. Rapp. 1985. Selective immortalization of murine macrophages from fresh bone marrow by raf/myc recombinant murine retrovirus. Nature 318: 667-670.
4. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
5. Brunner, D., N. Oeller, J. Szabad, H. W. Bigg III, S. L. Zipursky, and E. Hafen. 1994. A gain-of-function mutation in Drosophila MAP kinase activates multiple receptor tyrosine kinase signalling pathways. Cell 76:875-888.
6. Büscher, D., P. Dello-Sbarba, R. A. Hipskind, U. R. Rapp, R. E. Stanley, and M. Baccarini. 1993. v-raf confers CSF-1 independent growth to a macrophage cell line and leads to immediate early gene expression without MAP kinase activation. Oncogene 8:3323-3332.
7. Chang, F., and I. Herskowitz. 1990. Identification of a gene necessary for cell cycle arrest by a negative growth factor of yeast: FAR1 is an inhibitor of a G1 cyclin, CLN2. Cell 63:999-1011.
8. Chen, R.-H., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of erk-and rsk-encoded protein kinases. Mol. Cell. Biol. 12:915-927.
9. Chirgwin, J. M., A. E. Przybyla, R. I. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
10. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells. Cell 77:841-852.
11. Dahmer, M. K., and R. L. Perlman. 1988. Insulin and insulin-like growth factors stimulate deoxyribonucleic acid synthesis in PC12 pheochromocytoma cells. Endocrinology 122:2109-2113.
12. Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X. F. Wang. 1995. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545-5549.
13. Decker, S. J. 1995. Nerve growth factor-induced growth arrest and induction of p21Cip1/Waf1 in NIH-3T3 cells expressing RrkA. J. Biol. Chem. 270: 30841-30844.
14. Del-Sal, G., M. Murphy, E. Ruaro, D. Lazarevic, A. J. Levine, and C. Schneider. 1996. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene 12:177-185.
15. Deng, C., P. Zhang, J. W. Harper, J. S. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
16. Diaz-Benjumea, F. J., and E. Hafen. 1994. The sevenless signalling cassette mediates Drosophila EGF receptor function during epidermal development. Development 120:569-578.
17. Dikic, I., J. Schlessinger, and I. Lax. 1994. PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr. Biol. 4:702-708.
18. Dotto, G. P., L. F. Parada, and R. A. Weinberg. 1985. Specific growth response of ras-transformed embryo fibroblasts to tumor promoters. Nature 318:472-475.
19. Dulic, V., L. F. Drullinger, E. Lees, S. I. Reed, and G. H. Stein. 1993. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive E-cdk2 and cyclin D1-cdk2 complexes. Proc. Natl. Acad. Sci. USA 90:11034-11037.
20. el-Deiry, W., J. W. Harper, P. M. O'Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, et al. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169-1174.
21. el-Deiry, W., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
22. Evan, G. I., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610-3616.
23. Fantl, V., G. Stamp, A. Andrews, I. Rosewell, and C. Dickson. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:2364-2372.
24. Freeman, M. 1997. Cell determination strategies in the Drosophila eye. Development 124:261-270.
25. Gomez, N., and P. Cohen. 1991. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 351:69-72.
26. Graf, T., F. von Weizsaecker, S. Grieser, J. Coll, D. Stehelin, T. Patschinsky, K. Bister, C. Bechade, G. Calothy, and A. Leutz. 1986. V-mil induces autocrine growth and enhanced tumorigenicity in v-myc-transformed avian macrophages. Cell 45:357-364.
27. Guo, K., J. Wang, V. Adres, R. C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:3823-3829.
28. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connel-Crowley, E. Swindell, M. P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
29. Herzog, H., L. Hoefferer, R. Schneider, and M. Schweiger. 1990. cDNA encoding the human homologue of rat ribosomal protein L35a. Nucleic Acids Res. 18:4000.
30. Howe, L. R., S. J. Leevers, N. Goméz, S. Nakielny, P. Cohen, and C. J. Marshall. 1992. Activation of the MAP kinase pathway by the protein kinase Raf. Cell 71:335-342.
31. Huff, K., D. End, and G. Guroff. 1981. Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor. J. Cell Biol. 88:189-198.
32. Hunter, T. 1995. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signalling. Cell 80:225-236.
33. Ikawa, S., M. Fukui, Y. Ueyama, N. Tamaoki, T. Yamamoto, and K. Toyoshima. 1988. B-raf, a new member of the raf family, is activated by DNA rearrangement. Mol. Cell. Biol. 8:2651-2654.
34. Jansen, H. W., B. Rückert, R. Lurz, and K. Bister. 1983. Two unrelated cell-derived sequences in the genome of avian leukemia and carcinoma inducing retrovirus MH2. EMBO J. 2:1969-1975.
35. Kemppainen, J. A., M. V. Lane, S. Madhabananda, and E. M. Wilson. 1992. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. J. Biol. Chem. 267:968-974.
36. Kolch, W., G. Heidecker, P. Lloyd, and U. R. Rapp. 1991. Raf-1 protein kinase is required for growth of induced N1H/3T3 cells. Nature 349:426-428.
37. Kosako, H., Y. Gotoh, S. Matsuda, M. Ishikawa, and E. Nishida. 1992. Xenopus MAP kinase activator is a serine/threonine/tyrosine kinase activated by threonine phosphorylation. EMBO J. 11:2903-2908.
38. Kyriakis, J., H. App, X. Zhang, P. Banerjee, D. Brautigan, U. Rapp, and J. Avruch. 1992. Raf-1 activates MAP kinase-kinase. Nature 353:417-421.
39. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602.
40. Leevers, S. J., and C. J. Marshall. 1992. Activation of extracellular signal-regulated kinase. ERK2, by p21ras oncoprotein. EMBO J. 11:569-574.
41. Leevers, S. J., H. F. Paterson, and C. J. Marshall. 1994. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369:411-414.
42. mapkk) in fibroblasts. J. Cell Biol. 122:1079-1088.
43. 1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15:3654-3663.
44. Liu, Y., J. L. Martindale, M. Gorospe, and N. J. Holbrook. 1996. Regulation of p21Waf1/Cip1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res. 56:31-35.
45. Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
46. Lloyd, A. C., F. Obermüller, S. Staddon, C. F. Barth, M. McMahon, and H. Land. 1997. Co-operating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11:663-677.
47. Lowy, D. R., and B. M. Willumsen. 1993. Function and regulation of Ras. Annu. Rev. Biochem. 62:851-891.
48. Lucibello, F. C., A. Sewing, S. Brüsselbach, C. Bürger, and R. Müller. 1993. Deregulation of cyclin D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J. Cell Sci. 105:123-133.
49. Lukas, J., M. Pagano, Z. Staskowa, G. Draetta, and J. Bartek. 1994. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9:707-718.
50. Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:935-944.
51. Markowitz, D., C. Hesdorffer, M. Ward, S. Goff, and A. Bank. 1990. Retroviral gene transfer using safe and efficient packaging cell lines. Ann. N. Y. Acad. Sci. 612:407-414.
52. Marshall, C. J. 1994. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4:82-89.
53. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
54. Metz, T., A. W. Harris, and J. M. Adams. 1995. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 82:29-36.
55. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-982.
56. Missero, C., F. Di Cunto, H. Kiyokawa, A. Koff, and G. P. Dotto. 1996. The absence of p21Cip1/Waf1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10:3065-3075.
57. Mittnacht, S., H. Paterson, M. F. Olson, and C. J. Marshall. 1997. Ras signalling is required for inactivation of the tumour suppressor pRb cell cycle control protein. Curr. Biol. 7:219-221.
58. Moodie, S. A., B. M. Willumsen, M. J. Weber, and A. Wolfman. 1993. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260:1658-1661.
59. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
60. Nakielny, S., P. Cohen, J. Wu, and T. W. Sturgill. 1992. MAP kinase activator from insulin-stimulated skeletal muscle is a protein threonine/tyrosine kinase. EMBO J. 11:2123-2129.
61. Noda, M., M. Ko, A. Ogura, D. G. Liu, T. Amano, T. Takano, and Y. Ikawa. 1985. Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line. Nature 318:73-75.
62. Obermüller, F., and H. Land. Unpublished data.
63. Oehlen, L. J. W. M., J. D. McKinney, and F. R. Cross. 1996. Ste12 and Mcm1 regulate cell cycle-dependent transcription of FAR1. Mol. Cell. Biol. 16: 2830-2837.
64. O'Shea, C. C., T. Crompton, I. R. Rosewell, A. C. Hayday, and M. J. Owen. 1996. Raf regulates positive selection. Eur. J. Immunol. 26:2350-2355.
65. Paulus, W., I. Baur, F. M. Boyce, X. O. Breakefield, and S. A. Reeves. 1996. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70:62-67.
66. Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and M. E. Ewen. 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386:177-181.
67. Pérez-Roger, I., D. L. C. Solomon, and H. Land. 1997. Myc activation of cyclin E/cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes. Oncogene 14: 2373-2381.
68. Peter, M., A. Gartner, J. Horecka, G. Ammerer, and I. Herskowitz. 1993. FAR1 links the signal transduction pathway to the cell cycle machinery in yeast. Cell 73:747-760.
69. Pritchard, C. A., M. L. Samuels, E. Bosch, and M. McMahon. 1995. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol. Cell. Biol. 15:6430-6442.
70. Pumiglia, K. M., and S. J. Decker. 1997. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 94:448-452.
71. Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J. Y. Kato, S. D. Bar, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
72. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669-1679.
73. Ridley, A. J., H. F. Paterson, M. Noble, and H. Land. 1988. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J. 7:1635-1645.
74. Ruley, E. H. 1983. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304:602-606.
75. Rusch, R., and M. Levine. 1996. Threshold responses to the dorsal regulatory gradient and the subdivision of primary tissue territories in the Drosophila embryo. Curr. Opin. Genet. Dev. 6:416-423.
76. Samuels, M. L., and M. McMahon. 1994. Inhibition of platelet-derived growth factor-and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing ΔRaf-1:ER, an estradiol-regulated form of Raf-1. Mol. Cell. Biol. 14:7855-7866.
77. Samuels, M. L., M. J. Weber, J. M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol. Cell. Biol. 13:6241-6252.
78. Schaap, D., J. van der Wal, L. R. Howe, C. J. Marshall, and W. J. van Blitterswijk. 1993. A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J. Biol. Chem. 268:20232-20236.
79. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
80. Sewing, A., C. Bürger, S. Brüsselbach, C. Schalk, F. C. Lucibello, and R. Müller. 1993. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J. Cell Sci. 104:545-554.
81. Sewing, A., V. Rönecke, C. Bürger, F. Funk, and R. Müller. 1994. Alternative splicing of human cyclin E. J. Cell Sci. 107:581-588.
82. Smith, M. R., G. Heidecker, U. R. Rapp, and H.-F. Kung. 1990. Induction of transformation and DNA synthesis after microinjection of raf proteins. Mol. Cell. Biol. 10:3828-3833.
83. Soddu, S., G. Blandino, R. Scardigli, S. Coen, A. Marchetti, M. G. Rizzo, G. Bossi, L. Cimino, M. Crescenzi, and A. Sacchi. 1996. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol. 134: 193-204.
84. Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. E. El-Houseini. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396.
85. Thompson, T. C., J. Southgate, G. Kitchener, and H. Land. 1989. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 56:917-930.
86. Timchenko, N. A., M. Wilde, M. Nakanishi, J. R. Smith, and G. J. Darlington. 1996. CCAAT/enhancer-binding protein α (C/EBPα) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev. 10: 804-815.
87. Traverse, S., N. Goméz, H. Paterson, C. Marshall, and P. Cohen. 1992. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Biochem. J. 288:351-355.
88. Traverse, S., K. Seedorf, H. Paterson, C. J. Marshall, and A. Ullrich. 1994. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol. 4:694-701.
89. Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-215.
90. van Grunsven, L. A., N. Billon, P. Savatier, A. Thomas, J. L. Urdiales, and B. B. Rudkin. 1996. Effect of nerve growth factor on the expression of cell cycle regulatory protein in PC12 cells: dissection of the neurotrophic response from the anti-mitogenic response. Oncogene 12:1347-1356.
91. Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74:205-214.
92. Warne, P. H., P. R. Viciana, and J. Downward. 1993. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364:352-355.
93. Wassarman, D. A., M. Themen, and G. M. Rubin. 1995. The Ras signalling pathway in Drosophila. Curr. Opin. Genet. Dev. 5:44-50.
94. Winston, J. T., S. R. Coats, Y. Z. Wang, and W. J. Pledger. 1996. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12:127-134.
95. Wood, K. W., H. Qi, G. D'Arcangelo, R. C. Armstrong, T. M. Roberts, and S. Halegoua. 1993. The cytoplasmic raf oncogene induces a neuronal pheno-type in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction. Proc. Natl. Acad. Sci. USA 90:5016-5020.
96. Cip1. Mol. Cell. Biol. 17:5598-5611.
97. Wu-Chou, S. S., M. Kitagawa, N. Xue, B. Xie, S. Garofolo, J. Cho, C. Deng, W. A. Horton, and X. Y. Fu. 1997. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386:288-292.